@article{bill_revisiting_2019,
	title = {Revisiting {CLEC} {12A} as leukaemic stem cell marker in {AML}: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy},
	volume = {184},
	shorttitle = {Revisiting {CLEC} {12A} as leukaemic stem cell marker in {AML}},
	url = {https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711},
	number = {5},
	journal = {British journal of haematology},
	author = {Bill, Marie and Aggerholm, Anni and Kjeldsen, Eigil and Roug, Anne S. and Hokland, Peter and Nederby, Line},
	month = mar,
	year = {2019},
	pages = {769--781},
}

{"_id":"octjsWbd5skQqZtFi","bibbaseid":"bill-aggerholm-kjeldsen-roug-hokland-nederby-revisitingclec12aasleukaemicstemcellmarkerinamlhighlightingthenecessityofprecisiondiagnosticsinpatientseligiblefortargetedtherapy-2019","author_short":["Bill, M.","Aggerholm, A.","Kjeldsen, E.","Roug, A. S.","Hokland, P.","Nederby, L."],"bibdata":{"bibtype":"article","type":"article","title":"Revisiting CLEC 12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy","volume":"184","shorttitle":"Revisiting CLEC 12A as leukaemic stem cell marker in AML","url":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711","number":"5","journal":"British journal of haematology","author":[{"propositions":[],"lastnames":["Bill"],"firstnames":["Marie"],"suffixes":[]},{"propositions":[],"lastnames":["Aggerholm"],"firstnames":["Anni"],"suffixes":[]},{"propositions":[],"lastnames":["Kjeldsen"],"firstnames":["Eigil"],"suffixes":[]},{"propositions":[],"lastnames":["Roug"],"firstnames":["Anne","S."],"suffixes":[]},{"propositions":[],"lastnames":["Hokland"],"firstnames":["Peter"],"suffixes":[]},{"propositions":[],"lastnames":["Nederby"],"firstnames":["Line"],"suffixes":[]}],"month":"March","year":"2019","pages":"769–781","bibtex":"@article{bill_revisiting_2019,\n\ttitle = {Revisiting {CLEC} {12A} as leukaemic stem cell marker in {AML}: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy},\n\tvolume = {184},\n\tshorttitle = {Revisiting {CLEC} {12A} as leukaemic stem cell marker in {AML}},\n\turl = {https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711},\n\tnumber = {5},\n\tjournal = {British journal of haematology},\n\tauthor = {Bill, Marie and Aggerholm, Anni and Kjeldsen, Eigil and Roug, Anne S. and Hokland, Peter and Nederby, Line},\n\tmonth = mar,\n\tyear = {2019},\n\tpages = {769--781},\n}\n\n\n\n","author_short":["Bill, M.","Aggerholm, A.","Kjeldsen, E.","Roug, A. S.","Hokland, P.","Nederby, L."],"key":"bill_revisiting_2019","id":"bill_revisiting_2019","bibbaseid":"bill-aggerholm-kjeldsen-roug-hokland-nederby-revisitingclec12aasleukaemicstemcellmarkerinamlhighlightingthenecessityofprecisiondiagnosticsinpatientseligiblefortargetedtherapy-2019","role":"author","urls":{"Paper":"https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.15711"},"metadata":{"authorlinks":{}},"downloads":1},"bibtype":"article","biburl":"https://bibbase.org/zotero/SOPHiAGENETICS","dataSources":["Pcpsxmwz8uxXtL843","vPYMrJTaJTbhFPPb4"],"keywords":[],"search_terms":["revisiting","clec","12a","leukaemic","stem","cell","marker","aml","highlighting","necessity","precision","diagnostics","patients","eligible","targeted","therapy","bill","aggerholm","kjeldsen","roug","hokland","nederby"],"title":"Revisiting CLEC 12A as leukaemic stem cell marker in AML: highlighting the necessity of precision diagnostics in patients eligible for targeted therapy","year":2019,"downloads":1}